Dermatologist Breaks Down Skin Care Buzzwords and Treatments

A $45 treatment that can save starving children is at risk due to cuts in US aid, which have frozen its supply. This situation highlights the urgent need for continued support to prevent child malnutrition.

Editor’s Note: This matters because access to affordable treatments is crucial for saving lives. The cuts in aid not only threaten the availability of these treatments but also reflect broader issues in global health funding and support for vulnerable populations.

Ozempic and other GLP-1 weight-loss drugs are seen as potential solutions to obesity, but they face opposition from fat activists who question the framing of obesity as a problem.

Editor’s Note: This discussion is important as it highlights the tension between medical perspectives on obesity and the views of fat activists. Understanding both sides can lead to a more nuanced conversation about health and body image.

As fall approaches, skincare expert Sabrina Alba shares essential tips for adjusting your routine. From a DIY glow mask to an activating serum, learn how to keep your skin healthy and radiant during the seasonal transition.

Editor’s Note: Changing your skincare routine with the seasons is crucial for maintaining healthy skin. Sabrina Alba's insights help you adapt to fall's unique challenges, ensuring your skin stays nourished and vibrant.

Dr. Marnie Nussbaum, a board-certified dermatologist, explains popular skin care terms and treatments on TODAY, detailing their benefits and risks.

Editor’s Note: Understanding skin care buzzwords is essential for making informed choices about treatments. Dr. Nussbaum's insights help demystify these terms, empowering viewers to take better care of their skin.

Trump's tariffs are expected to impact Ireland significantly, particularly affecting drugmakers who utilize tax strategies. This move raises concerns about economic repercussions in the region.

Editor’s Note: This matters because the tariffs could lead to increased costs for drugmakers in Ireland, potentially affecting the pharmaceutical industry and the economy. It highlights the ongoing trade tensions and their implications for international business.